GE HealthCare Technologies Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.2% | -0.8% | -1.1% | +6.3% | -2.3% | +1.5% | +5.7% | +1.8% | +2.2% | +0.6% | +0.3% | |
| – | -0.8% | -0.2% | -6.1% | +21.8% | -7.4% | -1.5% | +16.4% | +9.0% | -10.0% | -6.7% | -15.2% | |
| – | +3.6% | +2.4% | -21.4% | +77.2% | -19.0% | -14.4% | +52.2% | +6.4% | +12.7% | -49.4% | -7.9% | |
| – | +3.6% | +2.4% | -21.4% | +77.2% | -19.0% | -14.4% | +52.2% | +6.4% | +12.7% | -49.4% | -7.9% | |
| – | +4.1% | -5.2% | +0.8% | +3.6% | +2.4% | -0.6% | +2.9% | +4.6% | -15.5% | +19.8% | -18.1% | |
| – | -7.9% | +1.5% | +1.7% | +5.0% | -8.7% | +11.3% | +5.8% | +0.9% | -3.0% | +5.3% | +5.5% | |
| – | +0.2% | -0.1% | +1.5% | +0.2% | 0.0% | +1.8% | +0.3% | +0.2% | +0.4% | +11.6% | +0.2% | |
| – | -5.9% | -6.3% | +1.8% | -5.3% | -4.8% | +14.8% | -1.5% | -4.8% | -2.8% | +68.8% | -0.7% | |
| – | +0.3% | -2.1% | -3.1% | +6.2% | -3.6% | -1.1% | +5.7% | +1.4% | +1.5% | -0.3% | +0.1% | |
| – | +18.7% | -1.4% | -6.1% | +4.2% | +10.2% | +4.4% | -2.2% | +3.3% | -9.6% | -6.3% | -2.7% | |
| – | +15,842.9% | +0.1% | +0.3% | +0.1% | +44.2% | +31.2% | +6.5% | -5.3% | -76.3% | -72.6% | -98.6% | |
| – | +6.2% | -0.5% | -3.7% | +3.1% | +3.8% | +4.3% | -5.6% | +0.4% | +8.8% | +4.9% | -5.2% | |
| – | -17.7% | -2.2% | -0.2% | +13.0% | -20.0% | -9.3% | +22.4% | +0.1% | +14.7% | +6.7% | -0.4% | |
| – | +0.0% | +3.9% | +5.3% | +6.6% | +1.6% | +8.8% | +5.7% | +2.9% | +3.9% | +2.8% | +2.9% | |
| – | +41.5% | +27.2% | +24.5% | +21.8% | +27.5% | +16.8% | +12.7% | +9.6% | +12.1% | +7.1% | +9.6% | |
| – | +0.0% | +0.2% | +0.0% | +0.0% | +0.0% | +0.0% | -0.2% | -0.2% | +0.7% | -0.7% | -0.7% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.